GlassScriptPhysician profile
Mir Jaffer Asif
NPI 1477759389
$4,914.03
in general payments reported to CMS, 2019-2025
10 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.87 · 2020: $21.51 · 2021: $36.22 · 2022: $4,349 · 2023: $94.93 · 2024: $192 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,314.85 | 2022-2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $146.58 | 2020-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $135.36 | 2021-2024 | |
| Ethicon INC. | $92.72 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.79 | 2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $50.07 | 2025 | Fasenra, Tezspire |
| Philips North America LLC | $47.18 | 2019-2022 | |
| Mylan Specialty L.P. | $29.43 | 2024 | Yupelri |
| Viatris Specialty LLC | $23.48 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $22.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mir Asif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.